An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.
Dhiren F PatelTeresa PeiróAmelia ShoemarkSamia AktharSimone A WalkerAleksander M GrabiecPatricia L JacksonTracy HussellAmit GaggarXin XuJennifer L TrevorJindong LiChad SteeleGael TavernierJ Edwin BlalockRobert M NivenLisa G GregoryAngela SimpsonClare M LloydRobert J SnelgrovePublished in: Science translational medicine (2019)
It is anticipated that bioactive fragments of the extracellular matrix (matrikines) can influence the development and progression of chronic diseases. The enzyme leukotriene A4 hydrolase (LTA4H) mediates opposing proinflammatory and anti-inflammatory activities, through the generation of leukotriene B4 (LTB4) and degradation of proneutrophilic matrikine Pro-Gly-Pro (PGP), respectively. We show that abrogation of LTB4 signaling ameliorated inflammation and airway hyperresponsiveness (AHR) in a murine asthma model, yet global loss of LTA4H exacerbated AHR, despite the absence of LTB4 This exacerbated AHR was attributable to a neutrophil-independent capacity of PGP to promote pathological airway epithelial remodeling. Thus, we demonstrate a disconnect between airway inflammation and AHR and the ability of a matrikine to promote an epithelial remodeling phenotype that negatively affects lung function. Subsequently, we show that substantial quantities of PGP are detectable in the sputum of moderate-severe asthmatics in two distinct cohorts of patients. These studies have implications for our understanding of remodeling phenotypes in asthma and may rationalize the failure of LTA4H inhibitors in the clinic.
Keyphrases
- extracellular matrix
- lung function
- cystic fibrosis
- anti inflammatory
- chronic obstructive pulmonary disease
- air pollution
- end stage renal disease
- ejection fraction
- newly diagnosed
- primary care
- chronic kidney disease
- oxidative stress
- early onset
- prognostic factors
- mycobacterium tuberculosis
- allergic rhinitis
- pulmonary tuberculosis
- patient reported
- patient reported outcomes
- case control